Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation

Cancer Genetics and Cytogenetics

Volumn 118, Issue 1, 2000, Pages 42-47

  Adeyinka, Adewale ^a   Mertens, Fredrik ^a   Bondeson, Lennart ^a   Garne, Jens Peter ^a   Borg, Åke ^a   Baldetorp, Bo ^a   Pandis, Nikos ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Papanikolaou Res Center of Oncology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

AGED; ARTICLE; BILATERAL CANCER; BREAST CANCER; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME 16; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLONE; CYTOGENETICS; FLOW CYTOMETRY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METAPHASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME;

AGED; ANEUPLOIDY; BRCA2 PROTEIN; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CLONE CELLS; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; Y CHROMOSOME;

EID: 0034175912     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00150-8     Document Type: Article

References (40)

1. Donegan W.L., Redlich P.N. Breast cancer in men. Surg Clin North Am. 76:1996;343-363.
2. Winchester D.J. Male breast cancer. Semin Surg Oncol. 12:1996;364-369.
3. Willsher P.C., Leach I.H., Ellis I.O., Bell J.A., Elston C.W., Bourke J.B., Blamey R.W., Robertson J.F. Male breast cancer. pathological and immunohistochemical features Anticancer Res. 17:1997;2335-2338.
4. Wolman S.R., Sanford J., Ratner S., Dawson P.J. Breast cancer in males. DNA content and sex chromosome constitution Mod Pathol. 8:1995;239-243.
5. Willsher P.C., Leach I.H., Ellis I.O., Bourke J.B., Blamey R.W., Robertson J.F. A comparison outcome of male breast cancer with female breast cancer. Am J Surg. 173:1997;185-188.
6. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G., Barfoot R., Hamoudi R., Patel S., Rice C., Biggs P., Hashim Y., Smith A., Connor F., Arason A., Gudmundsson J., Ficenec D., Kelsell D., Ford D., Tonin P., Bishop D.T., Spurr N.K., Ponder B.A.J., Eeles R., Peto J., Devilee P., Cornelisse C., Lynch H., Narod S., Lenoir G., Egilsson V., Barkadottir R.B., Easton D.F., Bentley D.R., Futreal P.A., Ashworth A., Stratton M.R. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
7. Wooster R., Mangion J., Eeles R., Smith S., Dowsett M., Averill D., Barrett-Lee P., Easton D.F., Ponder B.A., Stratton M.R. A germline mutation in the androgen receptor gene in two brothers with cancer and Reifenstein syndrome. Nature Genet. 2:1992;132-134.
8. Kapdi C.C., Parekh N.J. The male breast. Radiol Clin North Am. 21:1983;137-148.
9. Gollamudi S.V., Gelman R.S., Peiro G., Schneider L.J., Schnitt S.J., Recht A., Silver B.J., Harris J.R., Conolly J.L. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer. 79:1997;1362-1369.
10. Greene M.H. Genetics of breast cancer. Mayo Clinic Proc. 72:1997;54-65.
11. Anderson D.E., Badzioch M.D. Bilaterality in familial breast cancer patients. Cancer. 56:1985;2092-2098.
12. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom Cancer. 21:1998;177-184.
13. Tirkkonen M., Kainu T., Loman N., Jóhansson ÓT., Olsson H., Barkardóttir R.B., Kallioniemi O., Borg Å Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosom Cancer. 24:1999;56-61.
14. Teixeira M.R., Pandis N., Dietrich C.U., Reed W., Andersen J., Qvist J., Heim S. Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosom Cancer. 23:1998;16-20.
15. Histologic typing of breast tumors. Second International Histologic Classification of Tumors. 1981;World Health Organization, Geneva.
16. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histopathological grade in breast cancer. experience from a large study with long term follow up Histopathology. 19:1991;403-410.
17. Pandis N., Heim S., Bardi G., Limon J., Mandahl N., Mitelman F. Improved technique for short-term culture and cytogenetic analysis of human breast cancer. Genes Chromosom Cancer. 5:1992;14-20.
18. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
19. Baldertorp B., Dalberg M., Holst U., Lindgren G. Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry. 10:1989;695-705.
20. Baldertorp B., Fernö M., Fallenius A., Fallenius-Vecchi G., Idvall I., Olsson H., Sigurdsson H., Åkerman A., Killander D. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry. 13:1992;577-585.
21. Håkansson S., Johansson J., Johansson U., Sellberg G., Loman N., Gerdes A.M., Holmberg E., Dahl N., Kristoffersson U., Olsson H., Borg Å Moderate frequency of BRCA1 and BRCA2 germline mutation in Scandinavian familial breast cancer. Am J Hum Genet. 60:1997;1068-1078.
22. Haraldsson K., Loman N., Zhang Q.-X., Johansson O., Olsson H., Borg Å BRCA2 germline mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res. 58:1998;1367-1371.
23. Visscher D.W., Zarbo R.J., Greenawald K.A., Crissman J.D. Prognostic significance of morphological parameters and flowcytometric DNA analysis in carcinoma of the breast. Pathol Annu. 25:1990;171-210.
24. Heim S., Teixeira M.R., Dietrich C.U., Pandis N. Cytogenetic polyclonality in tumors of the breast. Cancer Genet Cytogenet. 95:1997;16-19.
25. Mitelman F. Catalog of Chromosome Aberrations in Cancer. 6th Ed:1998;Wiley-Liss, New York.
26. Mitchell E.L. A cytogenetic study of male breast cancer. Cancer Genet Cytogenet. 47:1990;107-112.
27. Pandis N., Jin Y., Gorunova L., Petersson C., Bardi G., Idvall I., Johansson B., Ingvar C., Mandahl N., Mitelman F., Heim S. Chromosome analysis of 97 primary carcinomas. identification of eight karyotypic subgroups Genes Chromosom Cancer. 12:1995;173-185.
28. Nishizaki T., DeVries S., Chew K., Goddson W.H. III, Ljung B.-M., Thor A., Waldman F.M. Genetic alterations in primary breast cancers and their metastases. direct comparison using modified comparative genomic hybridization Genes Chromosom Cancer. 19:1997;267-272.
29. Driouch K., Dorion-Bonnet F., Brifford M., Champème M.-H., Longy M., Lidereau R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosom Cancer. 19:1997;185-191.
30. Pandis N., Teixeira M.R., Adeyinka A., Rizou G., Bardi G., Mertens F., Andersen J.A., Bondeson L., Sfikas K., Qvist H., Apostolikas N., Mitelman F., Heim S. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosom Cancer. 22:1998;122-129.
31. Adeyinka A., Pandis N., Nilsson J., Idvall I., Mertens F., Petersson C., Heim S., Mitelman F. Different cytogenetic patterns in skeletal breast cancer metastases. Genes Chromosom Cancer. 16:1996;72-74.
32. Elfving P., Cigudosa J.C., Lundgren R., Limon J., Mandahl N., Kristoffersson U., Heim S., Mitelman F. Trisomy 7, trimosy 10, and loss of the Y chromosome in short-term cultures on normal kidney tissue. Cytogenet Cell Genet. 53:1990;123-125.
33. United Kingdom Cancer Cytogenetics Group (UKCCG) (1992): Loss of Y chromosome from normal and neoplastic bone marrows. Genes Chromosom Cancer 5:83-88.
34. Guttenbach M., Koschorz B., Bernthaler U., Grimm T., Schmid M. Sex chromosome loss and aging. in situ hybridization studies on human interphase nuclei Am J Hum Genet. 57:1995;1143-1150.
35. Jin C., Jin Y., Wennerberg J., Åkervall J., Grenthe B., Mandahl N., Heim S., Mitelman F., Mertens F. Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat Res. 374:1997;63-72.
36. Riske B.C., Morgan R., Ondreyco S., Sandberg A.A. X and Y chromosome loss as sole abnormality in acute non-lymphocytic leukemia (ANLL). Cancer Genet Cytogenet. 72:1994;44-47.
37. Hunter S., Gramlich T., Abbott K., Varma V. Y chromosome loss in esophageal carcinoma. an in situ hybridization study Genes Chromsom Cancer. 8:1993;172-177.
38. Mertens F., Johansson B., Mitelman F. Age- and gender-related heterogeneity of cancer chromosome aberrations. Cancer Genet Cytogenet. 70:1993;6-11.
39. Pandis N., Teixeira M.R., Gerdes A.-M., Limon J., Bardi G., Andersen J.A., Idvall I., Mandahl N., Mitelman F., Heim S. Chromosome abnormalities in bilateral breast carcinomas. Cancer. 76:1995;250-258.
40. Adeyinka A., Mertens F., Idvall I., Bondeson L., Ingvar C., Mitelman F., Pandis N. Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomas. Int J Cancer. 84:1999;370-375.